Can Lycopene Impact the Androgen Axis in Prostate Cancer?: A Systematic Review of Cell Culture and Animal Studies

First-line therapy for advanced or metastatic prostate cancer (PCa) involves the removal of tumor-promoting androgens by androgen deprivation therapy (ADT), resulting in transient tumor regression. Recurrent disease is attributed to tumor adaptation to survive, despite lower circulating androgen con...

Descripción completa

Detalles Bibliográficos
Autores principales: Applegate, Catherine C., Rowles, Joe L., Erdman, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471887/
https://www.ncbi.nlm.nih.gov/pubmed/30875962
http://dx.doi.org/10.3390/nu11030633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471887/
https://www.ncbi.nlm.nih.gov/pubmed/30875962
http://dx.doi.org/10.3390/nu11030633

Ejemplares similares